← All stocks

BIO vs PODD

Bio-Rad Laboratories Inc. Class A Common Stock vs Insulet Corporation Common Stock. Side-by-side ACCE scores, valuation, profitability, and growth.

BIO
Bio-Rad Laboratories Inc. Class A Common Stock
Healthcare
376.41
10.07B
PODD
Insulet Corporation Common Stock
Healthcare
140.60
9.75B
ACCE scores
BIO
PODD
Composite score
Out of 100
59
62
Growth
35
88
Value
41
55
Quality
62
89
Momentum
97
17
Valuation
BIO
PODD
Price
376.41
140.60
Market cap
10.07B
9.75B
Trailing P/E
45.85
26.38
Forward P/E
40.98
18.21
EV / EBITDA
17.18
15.58
Dividend yield
0.0%
0.0%
Profitability
BIO
PODD
ROE
3.1%
26.0%
Net margin
8.6%
12.3%
Debt / equity
0.16
0.63
Free cash flow
374.60M
377.70M
Growth
BIO
PODD
Revenue growth (YoY)
-0.1%
23.5%
Earnings growth (YoY)
18.7%
3.3%
Analyst target
329.00
171.91
See full analysis